Brief: Harpoon Provides Progress Update For TriTAC Clinical Programs And ProTriTAC Platform

Harpoon Therapeutics

04/06/2021 23:04

June 4 (Reuters) - Harpoon Therapeutics Inc  HARP.O :
    * HARPOON THERAPEUTICS PROVIDES PROGRESS UPDATE FOR TRITAC®
CLINICAL PROGRAMS AND PROTRITAC™ PLATFORM
    * HARPOON THERAPEUTICS - THREE TRITAC CLINICAL PROGRAMS HAVE
SHOWN
TUMOR SIZE REDUCTIONS OR STABLE DISEASE, AND MEANINGFUL
TREATMENT DURATION
    * HARPOON THERAPEUTICS INC - ALL FOUR CLINICAL PROGRAMS
DEMONSTRATE HALF-LIFE EXTENSION, TARGET ENGAGEMENT AND T CELL
ACTIVATION
    * HARPOON THERAPEUTICS INC - CYTOKINE RELEASE SYNDROME
OBSERVED
AND MANAGEABLE, WITH LOW INCIDENCE OF SEVERE CRS

Source text for Eikon:  ID:nGNX3Z1Y4N 
Further company coverage:  HARP.O 

 ((Reuters.Briefs@thomsonreuters.com;))